Status:
UNKNOWN
Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease
Lead Sponsor:
Mount Sinai Hospital, Canada
Collaborating Sponsors:
Crohn's and Colitis Canada
Conditions:
Inflammatory Bowel Disease
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Inflammatory Bowel Diseases (IBD) refers to a category of disorders, consisting of Crohn's Disease (CD) and Ulcerative Colitis (UC), where segments of the gastrointestinal tract become inflamed and ul...
Detailed Description
Inflammatory Bowel Diseases (IBD) refers to a category of disorders, consisting of Crohn's Disease (CD) and Ulcerative Colitis (UC), where segments of the gastrointestinal tract become inflamed and ul...
Eligibility Criteria
Inclusion
- Ability to provide informed consent
- Confirmed diagnosis of Crohn's Disease or Ulcerative Colitis
- Recruited from an IBD urgent care clinic
Exclusion
- Subjects who can't communicate in English
- Subjects who are read or write in English
- Subjects who lack internet access
- Subjects who lack access to a personal smartphone
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT03239704
Start Date
December 1 2018
End Date
December 1 2020
Last Update
September 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G1X5